The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008
NCT04187248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1248
Last updated 2023-08-25
Summary
Evaluation of the association between risk and severity of asparaginase associated toxicities and asparaginase enzyme activity levels in children with Acute Lymphoblastic Leukemia treated in the NOPHO-ALL 2008 protocol.
Conditions
Interventions
- DRUG
-
Asparaginase
Sponsors & Collaborators
-
Aarhus University Hospital
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-01
- Primary Completion
- 2016-02-28
- Completion
- 2017-03-01
Countries
- Denmark
Study Locations
More Related Trials
-
Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL)
NCT01094392 ·Status: COMPLETED
-
Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol
NCT04825548 ·Status: COMPLETED
-
Real World Asparaginase Therapy Toxicity
NCT07008027 ·Status: NOT_YET_RECRUITING
-
Outcome Following Truncation of Asparaginase
NCT03987542 ·Status: COMPLETED
-
NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia
NCT00548431 ·Status: COMPLETED ·Phase: PHASE2
-
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
NCT00400946 ·Status: COMPLETED ·Phase: PHASE3
-
Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL
NCT06195735 ·Status: COMPLETED
-
A Study of Children With Refractory or Relapsed ALL
NCT00187083 ·Status: COMPLETED ·Phase: PHASE3
-
Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL
NCT01228331 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Coagulopathy in Childhood Acute Lymphoblastic Leukaemia
NCT06242353 ·Status: NOT_YET_RECRUITING
-
Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
NCT00549848 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00430118 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Adults With Untreated Acute Lymphoblastic Leukemia
NCT00136435 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)
NCT02864290 ·Status: TERMINATED ·Phase: PHASE1
-
Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)
NCT03668392 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML
NCT01861002 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)
NCT04079296 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998
NCT01298388 ·Status: UNKNOWN
-
The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
NCT01886651 ·Status: COMPLETED
-
Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00764907 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
NCT00002499 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00343369 ·Status: UNKNOWN ·Phase: NA
-
Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00003437 ·Status: UNKNOWN ·Phase: PHASE3
-
Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL
NCT01225874 ·Status: COMPLETED ·Phase: NA
-
Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement
NCT03701295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2